ADPT
ADPT
NASDAQ · Life Sciences Tools & Services

Adaptive Biotechnologies

Mid-Cap Stocks Healthcare Stocks
$27.98
+1.15 (+4.29%)
As of Nov 7, 1:39 AM ET ·
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Buy 13 87%
Hold 2 13%
Sell 0 0%
Price Target
Analyst Price Target +208.1% upside
Low Target $68.90
Average Target $86.20
High Target $131.13
Current Price $27.98
Current
$27.98
Target
$86.20
$68.90 $86.20 avg $131.13
Scenario Analysis
Bear Case
$68.90
146.2%
Low target
Base Case
$86.20
+208.1%
Avg target
Bull Case
$131.13
+368.7%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$30.74
-9.0% from high
52-Week Low
$12.00
+133.2% from low
50-Day SMA
$26.42
+5.9% vs SMA
200-Day SMA
$19.82
+41.2% vs SMA
RSI (14)
66.1
Neutral
Target vs 52W High
$86.20
+180.4% vs high
Peer Consensus — Life Sciences Tools & Services
Stock Consensus Analysts Buy % Target Upside
TMO
Thermo Fisher Scientific Inc
 Strong Buy 35 86% $369.21 -46.9%
DHR
Danaher Corp
 Strong Buy 31 87% $158.11 -31.3%
A
Agilent Technologies Inc
 Buy 29 72% $64.69 -63.0%
IQV
Iqvia Holdings Inc
 Strong Buy 27 85% $82.96 -69.5%
WAT
Waters Corp
 Buy 30 70% $189.60 -58.6%
MTD
Mettler-Toledo International
 Hold 19 47% $170.43 -90.1%
ILMN
Illumina Inc
 Buy 28 57% $169.36 -20.5%
WST
West Pharmaceutical Services
 Strong Buy 22 95% $136.24 -65.9%